Chronic Plaque Psoriasis Market is segmented By Drug Class (Biologics, Small Molecule Drugs), By Rou...
Market Size in USD Bn
CAGR6.7%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 6.7% |
Market Concentration | High |
Major Players | Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson (Janssen Biotech), Amgen Inc. and Among Others |
The chronic plaque psoriasis market is estimated to be valued at USD 24.43 Bn in 2025 and is expected to reach USD 38.47 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032. The rising prevalence of autoimmune and inflammatory diseases is expected to boost the number of new patients entering the market.